http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008127743-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8491f63c1b8b29f136f3ee7beddbe98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_680dd0699e3f4ba8532d128c7152b3bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad2ab11e142e6a9b0ebd76cecd55eb9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5672312571ff9260c0556e11eeb98bfe
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6455
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
filingDate 2008-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb5a3093cd32c39cf8cbf6688910cd36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bc9c571407be76d9a92331023eed06a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33bd53b952f665206d85f9c80c9f8da5
publicationDate 2009-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008127743-A3
titleOfInvention Composition for targeted drug delivery and controlled release
abstract Disclosed herein are novel targeted drug delivery and controlled release methods and compositions where optically absorbing nanoparticles, such as nanoshells, are functionalized on their surfaces with thermolabile molecules that bind the drug molecules to be delivered. The linkage between the thermolabile moiety on the nanoparticles and the drug is deliberately designed or selected to be temperature sensitive, so that upon illumination of the nanoparticle at a wavelength of light, the drug molecules on the nanoparticles will be released. Targeting molecules, such as antibodies, aptamers or other molecules like folic acid, can be concurrently bound to the nanoparticle surface to deliver the nanoparticle to specifically targeted cells or tissues prior to the photothermally induced drug release. In this way the nanoparticles can be advantageously concentrated on the target prior to illumination, which makes the disclosed compositions both a targeted delivery and a controllable drug release vehicle.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9014779-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103649295-A
priorityDate 2007-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6428811-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395977

Total number of triples: 29.